Article

  • The EMBO Journal (1997) 16, 6364 - 6373
  • doi:10.1093/emboj/16.21.6364

Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses

Shigeru Tsuboi1 and Minoru Fukuda1

  1. The Glycobiology Program, La Jolla Cancer Research Center, The Burnham Institute, La Jolla, CA 92037, USA

Correspondence to:

Minoru Fukuda, E-mail: minoru@ljcrf.edu

Received 1 July 1997; Revised 19 August 1997


Core 2 beta-1,6-N-acetylglucosaminyltransferase, C2GnT, is a key enzyme in O-linked oligosaccharide (O-glycan) biosynthesis and the resultant core 2 branch serves as a backbone for additional glycosylation to form oligosaccharide ligands such as sialyl Lex. Since the expression of C2GnT is highly regulated during T-cell development and increases in pathological conditions such as the Wiskott–Aldrich syndrome, we have generated transgenic mice overexpressing C2GnT in the T-cell lineage. Surprisingly, T lymphocytes in the transgenic mice develop normally, but they exhibit a reduced immune response when assayed by delayed-type hypersensitivity, proliferation upon stimulation and cytokine production. Moreover, T lymphocytes from the transgenic mice adhere much less efficiently to ICAM-1 and fibronectin than do T lymphocytes from non-transgenic mice. These results indicate that overexpression of the core 2 branched O-glycans in T lymphocytes results in reduced immune responses due to impaired cell–cell interaction. Such an impaired immune response may be one of the causes for immunodeficiency in the Wiskott–Aldrich syndrome.

  • Keywords:

    • immunodeficiency,
    • N-acetylglucosaminyltransferase,
    • O-glycan,
    • T-cell response,
    • Wiskott–Aldrich syndrome